|
1) ATS. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005; 171: 388-416
|
|
|
|
2) 日本呼吸器学会｢呼吸器感染症に関するガイドライン作成委員会｣. 成人院内肺炎診療ガイドライン. 2008: 52-9
|
|
|
|
|
|
3) http://www.ihi.org/IHI/Topics/CriticalCare/IntensiveCare/Changes/ImplementtheVentilatorBundle.htm
|
|
|
|
|
|
4) Pingleton Sk, Fagon JY, Leeper KV Jr. Patient selection for clinical investigation of ventilator-associated with pneumonia: criteria for evaluating diagnostic techniques. Chest. 1992; 102: 553s-6s
|
|
|
|
|
|
5) Suka M, Yoshida K, Uno H, et al. Incidence and outcomes of ventilator-associated pneumonia in Japanese intensive care units: the Japanese nosocomial infection surveillance system. Infect Control Hosp Epidemiol. 2007; 28: 307-13
|
|
|
|
|
|
6) Niederman MS. Gram-negative colonization of the respiratory tract: pathogenesis and clinical consequences. Semin Respir Infect. 1990; 5: 173-84
|
|
|
|
|
|
7) Hoffken G, Niederman MS. Nosocomial Pneumonia: The importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU. Chest 2002; 122: 2183-96
|
|
|
|
|
|
8) Blot F, Raynard B, Chachaty E, et al. Value of Gram stain examination of lower respiratory tract secretions for early diagnosis of nosocomial pneumonia. Am J Respir Crit Care Med. 2000; 162: 1731-7
|
|
|
|
|
|
9) The Canadian Critical Care Trials Group. A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med. 2007; 355: 2619-30
|
|
|
|
|
|
10) Gibot S, Cravoisy A, Levy B, et al. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med. 2004; 350: 451-8
|
|
|
|
|
|
11) Luyt C, Guerin V, Combes A, et al. Procalcitonin kinetics as a prognostic marker of ventilator-asssociated pneumonia. Am J Respir Crit Care Med. 2005; 171: 48-53
|
|
|
|
|
|
12) Kollef MH, Morrow LE, Niederman MS, et al. Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. Chest. 2006; 129: 1210-8
|
|
|
|
|
|
13) Chastre J, Wolff M, Fagon JY, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults. JAMA. 2003; 290: 2588-98
|
|
|
|
|
|
14) Confalonieri M, Urbino R, Potena A, et al. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med. 2005; 171: 242-8
|
|
|
|
|
|
15) Dezfulian C, Shojania K, Collard HR, et al. Subglottic secretion drainage for preventing ventilator-associated pneumonia: a meta-analysis. Am J Med. 2005; 118: 11-8
|
|
|
|
|
|
16) Diaz E, Rodriguez AH, Rello J. Ventilator-associated pneumonia: issues related to the artificial airway. Respir Care. 2005; 50: 900-6
|
|
|
|
|
|
17) Lorente L, Lecuona M, Jimenez A, et al. Influence of an endotracheal tube with polyurethane cuff and subglottic secretion drainage on pneumonia. Am J Respir Crit Care Med. 2007; 176: 1079-83
|
|
|
|
|
|
18) Frutos-Vivar F, Esteban A, Apeztequia C, et al. Outcome of mechanically ventilated patients who require a tracheostomy. Crit Care Med. 2005; 33: 290-8
|
|
|
|
|
|
19) Kirton OC, Dehaven B, Morgan J, et al. A prospective, randomized comparison of an in-line heat moisture exchange filter and heated wire humidifiers: rates of ventilator-associated early-onset (community-acquied) or late-onset (hospital-acquired) pneumonia and incidence of endotracheal tube occlusion. Chest. 1997; 112: 1055-9
|
|
|
|
|
|
20) de Jonge E, Schultz MJ, Spanjaard L, et al. Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomized controlled trial. Lancet. 2003; 362: 1011-6
|
|
|
|
|
|
21) Singh PK, Parsek MR, Greenberg EP, et al. A component of innate immunity prevents bacterial biofilm development. Nature. 2002; 417: 552-5
|
|
|
|
|